Who invested in New Path Molecular?
One investor is on record as having backed New Path Molecular — Drug conjugates targeting solid tumours, in Healthcare. Each row below says whether the round came from the investor's own portfolio page or from the press.
newpathmolecular.comNew Path Molecular investors
No round dates are on record for New Path Molecular. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed New Path Molecular are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.